Literature DB >> 14143343

THE CLINICAL EVALUATION OF A NEW BUTYROPHENONE (WY-3457).

G M SIMPSON, T FARKAS, J C SAUNDERS.   

Abstract

Entities:  

Keywords:  ANTIDEPRESSIVE AGENTS; CHLORPROMAZINE; DRUG THERAPY; INSULIN; RESERPINE; SCHIZOPHRENIA

Mesh：

Substances：

Year:  1964        PMID： 14143343     DOI： 10.1007/BF02341263

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  6 in total

1.  Tourette's disease: relief of symptoms with R1625.

Authors:  G CHALLAS; W BRAUER
Journal:  Am J Psychiatry       Date:  1963-09       Impact factor: 18.112

2.  Cutaneous side effects from use of triparanol (MER-29): preliminary data on ichthyosis and loss of hair.

Authors:  W P ACHOR; R K WINKELMANN; H O PERRY
Journal:  Proc Staff Meet Mayo Clin       Date:  1961-04-26

3.  PHENOTHIAZINE-PRODUCED EXTRA-PYRAMIDAL SYSTEM DISTURBANCE.

Authors:  G M SIMPSON; D AMUSO; J H BLAIR; T FARKAS
Journal:  Arch Gen Psychiatry       Date:  1964-02

4.  A modified Malamud-Sands rating scale for use by ward personnel.

Authors:  W J TURNER; W KRUMHOLZ; S MERLIS
Journal:  Psychopharmacol Serv Cent Bull       Date:  1962-11

5.  [A case of tic of Gilles de la Tourette cured by R 1625].

Authors:  J N SEIGNOT
Journal:  Ann Med Psychol (Paris)       Date:  1961-03       Impact factor: 0.380

6.  Cataracts as possible complications of treatment with triparanol.

Authors:  T J KIRBY
Journal:  Arch Ophthalmol       Date:  1962-04
  6 in total
  1 in total

1.  [Pharmacologic and clinical properties of a new butyrophenone derivative (FR 33)].

Authors:  R Kuhn; M Taeschler; J Schoch
Journal:  Psychopharmacologia       Date:  1966
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.